Literature DB >> 9425026

Hybrid oligomer duplexes formed with phosphorothioate DNAs: CD spectra and melting temperatures of S-DNA.RNA hybrids are sequence-dependent but consistent with similar heteronomous conformations.

G M Hashem1, L Pham, M R Vaughan, D M Gray.   

Abstract

Knowledge of the relative stabilities of S-DNA.RNA hybrids of different sequences is important for choosing RNA targets for hybridization with antisense phosphorothioate oligodeoxyribonucleotides (S-DNAs). It is also important to know how hybrid secondary structure varies with sequence, since different structures could influence thermal stability and the activity of RNase H. Our approach has been to study relatively simple sequences consisting of repeating di-, tri-, and tetranucleotides, which allow the maximum resolution of nearest-neighbor effects. Circular dichroism (CD) spectra and melting temperatures were acquired for 16 hybrid sequences that could be formed by mixing S-DNA and RNA oligomers of 24 nucleotides in length. CD spectra of S-DNA.RNA hybrids were sequence-dependent and were similar to those of analogous unmodified hybrids. From singular value decomposition, the major CD spectral component was like that of the A-conformation. Three nearest-neighbor relationships among the hybrid CD spectra were in as good agreement as are such relationships among spectra of duplex RNAs. Tm values ranged from 44.1 degrees C for S-d(ACT)8. r(AGU)8 to 66.6 degrees C for S-d(CCT)8.r(AGG)8 (in 0.15 M K+, phosphate buffer, pH 7). The S-DNA.RNA hybrids had a sequence-dependence of melting temperatures that was approximately the same as that calculated using published data for normal DNA.RNA hybrids [Sugimoto, N., Nakano, S., Katoh, M., Matsumura, A., Nakamuta, H., Ohmichi, T.,Yoneyama, M., & Sasaki, M. (1995) Biochemistry 34, 11211-11216]. In general, sequence-dependent CD spectra and Tm values of S-DNA.RNA hybrids appear to reflect the unique nearest-neighbor interactions of adjacent base pairs, where the S-DNA and RNA strands are in different, but relatively uniform, conformations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9425026     DOI: 10.1021/bi9713557

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  The solution structure of [d(CGC)r(aaa)d(TTTGCG)](2): hybrid junctions flanked by DNA duplexes.

Authors:  S T Hsu; M T Chou; J W Cheng
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  The solution structure of [d(CGC)r(amamam)d(TTTGCG)]2.

Authors:  Y P Tsao; L Y Wang; S T Hsu; M L Jain; S H Chou; C Huang; J W Cheng
Journal:  J Biomol NMR       Date:  2001-11       Impact factor: 2.835

3.  Atomic detail investigation of the structure and dynamics of DNA.RNA hybrids: a molecular dynamics study.

Authors:  U Deva Priyakumar; Alexander D Mackerell
Journal:  J Phys Chem B       Date:  2008-01-16       Impact factor: 2.991

4.  Influence of divalent cations on the conformation of phosphorothioate oligodeoxynucleotides: a circular dichroism study.

Authors:  S D Patil; D G Rhodes
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

5.  Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.

Authors:  H Arima; M Takahashi; Y Aramaki; T Sakamoto; K Yuda; K Akiyama; T Goto; S Tsuchiya
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

6.  Antisense DNA parameters derived from next-nearest-neighbor analysis of experimental data.

Authors:  Donald M Gray; Carla W Gray; Byong-Hoon Yoo; Tzu-Fang Lou
Journal:  BMC Bioinformatics       Date:  2010-05-14       Impact factor: 3.169

7.  2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.

Authors:  Byong Hoon Yoo; Elena Bochkareva; Alexey Bochkarev; Tung-Chung Mou; Donald M Gray
Journal:  Nucleic Acids Res       Date:  2004-04-02       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.